Skip to main content

Table 1 Characteristics of study participants: patient group (n = 124)

From: Shared decision making, physicians’ explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients

Variables n %
Age group
 50–59 7 5.6
 60–69 40 32.3
 70–79 57 46.0
 80–89 20 16.1
Age (mean ± SD) 71.5 7.6
Occupation
 Employed (full-time) 22 17.7
 Employed (part-time) 19 15.3
 Homemaker 1 0.8
 Unemployed 78 62.9
 Other 4 3.2
Years after diagnosis
 < 2 years 29 23.4
 2–4 years 24 19.4
 4–6 years 28 22.6
 6–10 years 24 19.4
> 10 years 19 15.3
Years after drug therapy
 < 2 years 46 37.1
 2–4 years 21 16.9
 4–6 years 27 21.8
 6–10 years 17 13.7
> 10 years 13 10.5
Metastasis at diagnosis
 Bone metastasis 18 14.5
 Lymph node metastasis 13 10.5
 Organ metastasis (the lung, liver, etc.) 4 3.2
 No metastasis 94 75.8
 Unknown 3 2.4
Previous treatment
 Surgical therapy 40 32.3
 External irradiation 48 38.7
 Brachytherapy 3 2.4
 Hormone drugs (injection, oral drugs, etc.) 124 100.0
 Chemotherapy (anticancer drugs) 14 11.3
 Bone-modifying agents (drugs that suppress metastatic bone lesions) 7 5.6
 Radiopharmaceuticals (radium, strontium) 1 0.8